Compte rendu ‒ Conseil des ADPIC ‒ Afficher les détails de l'intervention/la déclaration

Ambassador Mero (United Republic of Tanzania)
Bolivie, État plurinational de
13 The United Nations Secretary-General's High-Level Panel Report on Access to Medicines
665. We would like to thank the delegations of Brazil, China, India and South Africa for having tabled this agenda item at the TRIPS Council. Access to medicines is of the highest priority for my country. For this reason, even though we continue to analyse the content of the Report of the UN SG HLP on access to medicines, as many will recall, the HLP had the participation of experts of worldwide reputation representing developing and developed countries. Their participation is quite democratic in that regard. Many of their findings are consistent with findings in the WHO in the past years, such as the Red Book of 1998 or the outcomes of the Committee on Public Health and IP in 2002 or the 2012 Report. So we attach great importance to this Report and the findings of this HLP and we hope to analyse it further in this Council.
The Council took note of the statements made and agreed to take the matter up as an ad hoc agenda item at its next meeting.
70. The Chairman said that Brazil, China, India and South Africa had requested that this item be added to the agenda. They had submitted a communication that briefly introduced the item, circulated in document IP/C/W/619.

71. The representatives of India, Brazil, South Africa, China, Ecuador, Egypt, Indonesia, Bangladesh, the Russian Federation, the United States, Canada, the European Union, Chile, Australia, Switzerland, Japan, the Republic of Korea, the Plurinational State of Bolivia and Norway took the floor.

72. The representatives of the Holy See, WHO, UNCTAD, and UNAIDS took the floor.

73. The representative of the Secretariat took the floor.

74. The Council took note of the statements made and agreed to take the matter up as an ad hoc agenda item at its next meeting.

IP/C/M/83, IP/C/M/83/Add.1